Contents

Search

N-PEP-12 (MemoProve)

Indications: - Alzheimer's disease (allegedly approved in 30 countries) Dosage: may be taken orally Mechanism of action: - derived from cerebrolysin, but less potent Clinical trials: 1) may be effective [1]

General

peptide

References

  1. Crook TH et al, Effects of N-PEP-12 on memory among older adults In Clin Psychoparmacol 2005, 20:97 PMID: 15729085

Components

cyclophosphamide (Cytoxan, Neosar, Procytox {Canadian}) [CPM, CTX, CYT, NSC 26271] pentostatin (Nipent, DCF, 2'deoxycoformycin) rituximab (Rituxan, Mabthera, Truxima, Ruxience, Riabni)